Why multitarget vasodilatory (endo)cannabinoids are not effective as antihypertensive compounds after chronic administration: comparison of their effects on systemic and pulmonary hypertension

HIGHLIGHTS

  • who: Patryk Remiszewski and Barbara Malinowska from the Department of Experimental Physiology and Pathophysiology, Medical University of Bialystok, Mickiewicza Str A, Biau0142ystok, Poland have published the Article: Why Multitarget Vasodilatory (Endo)cannabinoids Are Not Effective as Antihypertensive Compounds after Chronic Administration: Comparison of Their Effects on Systemic and Pulmonary Hypertension, in the Journal: Pharmaceuticals 2022, 15, 1119. of /2022/
  • what: The present review was aimed at determining (based on the available literature) the effects of chronic administration of_(endo)cannabinoids on BP in various models of systemic and pulmonary hypertension.

SUMMARY

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?